THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

FARALLON CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000909661)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 56,695,000 Value ($000) $54,114 Avg Close — Range —
Q1 2021
Shares 56,695,000 Value ($000) $57,933 Avg Close — Range —
Q4 2020
Shares 56,695,000 Value ($000) $53,806 Avg Close — Range —
Q3 2020
Shares 56,695,000 Value ($000) $49,808 Avg Close — Range —
Q2 2020
Shares 41,905,000 Value ($000) $40,869 Avg Close — Range —
Q1 2020
Shares 16,360,000 Value ($000) $15,685 Avg Close — Range —